Trial Profile
South Danish Diabetes Study: A Prospective Randomised Multi-Centre Study for the Evaluation of the Optimal Pharmacological Antidiabetic Treatment of Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin suspension isophane; Metformin; Rosiglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SDDS
- 01 Dec 2011 Results published in the Basic and Clinical Pharmacology and Toxicology.
- 23 Jun 2008 Status change
- 22 Jun 2007 Status changed from in progress to completed.